Virginia Commonwealth University
INVESTIGATION OF PHENYLEPHRINE SULFATION AND INHIBITION USING A NOVEL HILIC ASSAY METHOD
Abstract
dc:description.abstractPhenylephrine (PE) is the most commonly used over-the-counter nasal decongestant. The problem associated with phenylephrine is that it undergoes extensive first pass metabolism in the intestinal gut wall leading to its poor and variable oral bioavailability. This research project aims at developing strategies in order to increase the oral bioavailability of PE by co-administration of GRAS compounds. A HILIC assay method was developed to detect the parent drug, phenylephrine (PE) and its sulfate metabolite (PES).The enzyme kinetic studies were done with phenolic dietary or GRAS compounds using LS180 human intestinal cell model, recombinant SULT enzymes and human intestinal cytosol (HIC). From the screening studies done, one inhibitor was selected in order to study the mechanism of inhibition. In conclusion the studies done in vitro provided a basis in order to predict in vivo intrinsic clearance through the sulfation pathway.
Degree
thesis:*- Name thesis:degree_name
- Master of Pharmaceutical Sciences
- Level thesis:degree_level
- Thesis
- Discipline thesis:degree_discipline
- Pharmaceutical Sciences
Author and committee
dc:creator, dc:contributor.*- Author dc:creator
-
- Shah, Heta N
- Contributors dc:contributor
-
- Dr. Phillip Gerk
- Dr. Jurgen Venitz
- Dr. Joseph Ritter
Subjects
dc:subject × 4Rights
dc:rights- Statement dc:rights
-
- © The Author
Identifiers
dc:identifier.*- Identifier
- https://scholarscompass.vcu.edu/etd/3952